All In Biotech

Drug Trial Radar · NCT04554914

A Study to Evaluate Tabelecleucel in Participants With Epstein Barr Virus (EBV) Associated Diseases

An Open-label, Single-arm, Multicohort, Phase 2 Study to Assess the Efficacy and Safety of Tabelecleucel in Subjects With Epstein Barr Virus Associated Diseases (EBVision)

Last checked: Nov 19, 2026Latest source record: Jul 31, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

190

Planned (sponsor's estimate)

Start

Jul 14, 2021

Primary completion

Jun 2027

Study completion May 2028

Sponsor

Lead sponsor
Pierre Fabre MedicamentIndustry
Sponsor type
Industry
First posted
Sep 18, 2020

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Non randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to assess the efficacy and safety of tabelecleucel in participants with EBV-associated diseases.

Conditions

  • Epstein-Barr Virus (EBV)-Associated Diseases
  • EBV+ Lymphoproliferative Disease With Primary Immunodeficiency (EBV+ PID LPD)
  • EBV+ Lymphoproliferative Disease With Acquired (Non-congenital) Immunodeficiency (EBV+ AID LPD)
  • EBV+ Posttransplant Lymphoproliferative Disease in Central Nervous System (EBV+ CNS PTLD)
  • EBV+ Post-transplant Lymphoproliferative Disease (EBV+ PTLD)
  • Solid Organ Transplant Complications
  • Lymphoproliferative Disorders
  • Allogeneic Hematopoietic Cell Transplant
  • Stem Cell Transplant Complications
  • EBV+ Sarcomas
  • Leiomyosarcoma

Interventions

  • TabelecleucelBiological

    Tabelecleucel is being investigated as an off-the-shelf, allogeneic T-cell immunotherapy for the treatment of EBV+ malignancies and diseases.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Objective response rate (ORR)Time frame: Up to 2 years

Locations

40 sites in 7 countries. Site status is shown where the registry gives one.

  • University of California Los Angeles (UCLA) (Adults and Pediatrics)

    Los Angeles, California

  • Children's Hospital of Orange County (Pediatrics [up to 25 years old])

    Orange, California

  • Lucile Packard Children's Hospital Stanford (Pediatrics only)

    Palo Alto, California

  • University of California Davis Comprehensive Cancer Center (Adults and Pediatrics)

    Sacramento, California

  • Sylvester Comprehensive Cancer Center/ University of Miami

    Miami, Florida

  • Moffit Cancer Center (Adults only)

    Tampa, Florida

  • Children's Healthcare of Atlanta (Pediatrics only [up to 25 years old])

    Atlanta, Georgia

  • Emory University/Winship Cancer Institute (Adults [>= 16 years])

    Atlanta, Georgia

  • Ann & Robert H. Lurie Children's Hospital of Chicago (Pediatrics only)

    Chicago, Illinois

  • University of Maryland Medical Center (Adults only)

    Baltimore, Maryland

  • Dana Farber Cancer Institute (DFCI) (Adults and Pediatrics)

    Boston, Massachusetts

  • University of Michigan Rogel Cancer Center (Adults and Pediatrics)

    Ann Arbor, Michigan

  • University of Minnesota (Adults only)

    Minneapolis, Minnesota

  • Washington University in St. Louis (Adults only)

    St Louis, Missouri

  • Columbia University Irving Medical Center (Adults only)

    New York, New York

  • Memorial Sloan-Kettering Cancer Center (Adults and Pediatrics)

    New York, New York

  • The Children's Hospital at Montefiore (Adults and Pediatrics)

    The Bronx, New York

  • Cleveland Clinic Taussig Cancer Center (Adults and Pediatrics)

    Cleveland, Ohio

  • The Ohio State University - The James Cancer Hospital and Solove Research Institute (Adults only)

    Columbus, Ohio

  • Oregon Health and Science University (Adults and Pediatrics)

    Portland, Oregon

  • Medical University of South Carolina (Adults and Pediatrics)

    Charleston, South Carolina

  • University of Texas Southwestern Medical Center (Pediatrics only)

    Dallas, Texas

  • MD Anderson (Adults and Pediatrics)

    Houston, Texas

  • Uniklinikum Salzburg Landeskrankenhaus (Adults only)

    Salzburg, State of Salzburg, Austria

  • Medizinische Universität Wien (Adults only)

    Vienna, State of Vienna, Austria

  • Medizinische Universität Graz (Adults only)

    Graz, Styria, Austria

  • Hôpital Universitaire des Enfants Reine Fabiola (Pediatrics only)

    Brussels, Brussles, Belgium

  • Algemeen Ziekenhuis Sint-Jan Brugge-Oostende - Campus Sint-Jan (Adults only)

    Bruges, West-Vlaanderen, Belgium

  • Algemeen Ziekenhuis Delta - Campus Rumbeke (Adults only)

    Roeselare, West-Vlaanderen, Belgium

  • Hôpital Universitaire Pitié Salpêtrière (Adults only)

    Paris, France

  • Hôpital Saint-Eloi (Adults and Pediatrics)

    Montpellier, Montpellier, France

  • Hôpital Necker-Enfants Malades (Adults and Pediatrics)

    Paris, Paris, France

  • Azienda Ospedaliero-Universitaria Pisana (Adults only)

    Pisa, Pisa, Italy

  • Ospedale Pediatrico Bambino Gesù (Adults and Pediatrics)

    Roma, Roma, Italy

  • Ospedale Infantile Regina Margherita (Pediatrics only)

    Torino, Torino, Italy

  • Hospital Universitari Vall d'Hebrón (Adults and Pediatrics)

    Barcelona, Barcelona, Spain

  • Hospital Universitario Ramón y Cajal (Adults only)

    Madrid, Madrid, Spain

  • Hospital Universitario Virgen del Rocio (Adults and Pediatrics)

    Seville, Sevilla, Spain

  • University Hospital Birmingham NHS Foundation Trust (Adults only)

    Birmingham, England, United Kingdom

  • Great Ormond Street Hospital (Pediatrics only)

    London, England, United Kingdom

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.